Cabral-Miranda, G.; Heath, M.D.; Mohsen, M.O.; Gomes, A.C.; Engeroff, P.; Flaxman, A.; Leoratti, F.M.S.; El-Turabi, A.; Reyes-Sandoval, A.; Skinner, M.A.;
et al. Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax. Vaccines 2017, 5, 10.
https://doi.org/10.3390/vaccines5020010
AMA Style
Cabral-Miranda G, Heath MD, Mohsen MO, Gomes AC, Engeroff P, Flaxman A, Leoratti FMS, El-Turabi A, Reyes-Sandoval A, Skinner MA,
et al. Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax. Vaccines. 2017; 5(2):10.
https://doi.org/10.3390/vaccines5020010
Chicago/Turabian Style
Cabral-Miranda, Gustavo, Matthew D. Heath, Mona O. Mohsen, Ariane C. Gomes, Paul Engeroff, Amy Flaxman, Fabiana M. S. Leoratti, Aadil El-Turabi, Arturo Reyes-Sandoval, Murray A. Skinner,
and et al. 2017. "Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax" Vaccines 5, no. 2: 10.
https://doi.org/10.3390/vaccines5020010
APA Style
Cabral-Miranda, G., Heath, M. D., Mohsen, M. O., Gomes, A. C., Engeroff, P., Flaxman, A., Leoratti, F. M. S., El-Turabi, A., Reyes-Sandoval, A., Skinner, M. A., Kramer, M. F., & Bachmann, M. F.
(2017). Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax. Vaccines, 5(2), 10.
https://doi.org/10.3390/vaccines5020010
